TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government & Organizations

    This Week in Cardiology

    This podcast delivers Dr. John Mandrola’s summary and perspective on top news of the week that cardiologists can’t miss. This podcast is intended for US health professionals only.

    Advertise

    Copyright: © Copyright 2019, Medscape

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Oct 09 2026 This Week in Cardiology Oct 09, 2026
    Show notes

    Listener feedback on POET II, sham control trials in atrial fibrillation, ICDs in HCM, and agenda laundering are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback

    POET II Response-Tailored or Standard-Duration ABX for Infectious Endocarditis

    • POET I Trial https://www.nejm.org/doi/10.1056/NEJMoa1808312
    • POET II Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607887

    II PVI-SHAM-AF trial Back in the News

    • GAP-AF Trial https://www.ahajournals.org/doi/10.1161/circep.115.003337
    • PVI-SHAM-AF Trial 10.1016/S0140-6736(26)01558-8 External Link
    • Why Sham Studies Are a Sham in 2026 10.1016/j.hrthm.2026.09.056 External Link
    • The Indispensable Role of Sham Controls in Evaluating Interventional Therapies 10.1016/j.hrthm.2026.10.001 External Link

    III ICDs in HCM

    • I CDs for the Prevention of SCD in High-Risk Patients with HCM https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.125.078597
    • ICDs in HCM: Editorial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079687

    IV Agenda Laundering

    • How Commercial “Agenda Laundering” Shapes Critical Care https://www.bmj.com/content/395/bmj-2026-100963

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Oct 02 2026 This Week in Cardiology Oct 02, 2026
    Show notes

    Listener feedback on DANISH-CRT, the POET II trial, a mechanistic study in obesity and AF, the DANCODE trial of slowing CAC progression, and more on GLP-1 drugs are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback

    • DANISH-CRT Trial 10.1016/S0140-6736(26)01597-7
    • Identifying LV Posterior Wall Delay in RBBB Using Lead V8 https://doi.org/10.1016/j.jacep.2026.03.009
    • Using Lead V8 as a Tool to Improve Patient Selection in CRT https://doi.org/10.1093/europace/euaf194

    II POET II Response-Tailored or Standard-Duration Antibiotics for Endocarditis

    • POET I https://www.nejm.org/doi/10.1056/NEJMoa1808312
    • POET II https://www.nejm.org/doi/full/10.1056/NEJMoa2607887

    III Obesity and AF – A Neat Study from the Team in Prague

    • LA Remodeling and Functional Maladaptations in Obesity https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.126.014509

    IV Reducing CAC: The DANCODE Trial

    • DANCODE Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.082363

    V Two Big RCTs of New GLP-1 Drugs

    • TRIUMPH-1 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2604169
    • SYNCHRONIZE-2 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607219

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Sep 25 2026 This Week in Cardiology Sep 25, 2026
    Show notes

    Listener feedback, pulmonary embolism intervention, simple vs complex in BiV pacing, exercise in AF, and TAVR for paradoxical low-flow, low-gradient aortic stenosis are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback LBBP ICD Lead

    • LEADR LBBAP Trial https://pubmed.ncbi.nlm.nih.gov/41110529/

    TRIC-I-HF trial

    • TRIC-I-HF Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2606934
    • Growth of Tricuspid Interventions in Germany https://www.jacc.org/doi/10.1016/j.jcin.2025.05.030

    II Treatment of Acute Intermediate-High Risk PE – the PRAGUE-26 Trial

    • PRAGUE-26 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2608012

    III Targeting CS leads in CRT devices – DANISH-CRT Trial

    • DANISH-CRT Trial 10.1016/S0140-6736(26)01597-7

    IV Exercise for AF, Especially When There Is LA Disease

    • Physical Activity and Risk of Incident AF in Atrial Cardiomyopathy https://www.jacc.org/doi/10.1016/j.jacadv.2026.102999

    V Paradoxical Low-Flow, Low-Gradient AS – REBOOT-PARADOX

    • REBOOT-PARADOX trial 10.1016/j.jacc.2026.08.017
    • ROTAS Trial https://heart.bmj.com/content/110/20/1223

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Sep 18 2026 This Week in Cardiology Sep 18, 2026
    Show notes

    Another ESC recap, listener feedback on two trials, and a paper on GLP-1 effects on inflammation from the SELECT trial are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Correction on PROFID Trial

    II Listener Feedback

    III Fifth Universal Definition of MI

    • Fifth Universal Definition of MI https://doi.org/10.1093/eurheartj/ehag101
    • Foy/Mandrola Editorial on Troponin Use and Interpretation https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2777967

    IV New ESC HF Guidelines

    • ESC Guidelines for Management of HF https://doi.org/10.1093/eurheartj/ehag100
    • Sanjay Kaul on X https://x.com/kaulcsmc/status/2094959683215958158?s=20
    • Geographic Disparities in TOPCAT https://pmc.ncbi.nlm.nih.gov/articles/PMC5065247/

    V AIR STEMI Trial

    • AIR-STEMI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2605373
    • CR Strategies After MI https://www.jacc.org/doi/10.1016/j.jacc.2024.04.051
    • PRAMI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1305520
    • COMPLETE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1907775
    • FULL REVASC Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2314149

    VI GLP-1 News – A SELECT Trial Secondary Analysis

    • Semaglutide and hsCRP in Patients with CVD and Obesity https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.125.074482

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Sep 11 2026 This Week in Cardiology Sep 11, 2026
    Show notes

    A second ESC recap plus two breaking stories on the failure of an investigational Lp(a) reducing drug and a new FDA approval of an AI-ECG app are covered by John Mandrola, MD

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Lp(a) Disappointment

    • HORIZON https://clinicaltrials.gov/study/NCT04023552
    • Press Release https://www.novartis.com/news/media-releases/novartis-announces-lpahorizon-phase-iii-topline-results-pelacarsen-patients-elevated-lpa-and-established-cardiovascular-disease-cvd
    • Rationale paper https://doi.org/10.1016/j.ahj.2025.03.019

    II FDA Clears AI-ECG for Acute MI Detection

    • Accuracy of cath lab activation decisions for STEMI-equivalent and mimic ECGs: Physicians vs. AI (Queen of Hearts by PMcardio) 10.1016/j.ajem.2025.07.061
    • AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. Registry https://www.jacc.org/doi/10.1016/j.jcin.2025.10.018
    • Queen of Hearts™ AI ECG App https://www.powerfulmedical.com/pmcardio-stemi/

    III TARGET CTCA Trial

    • Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain https://www.nejm.org/doi/10.1056/NEJMoa2608903

    IV CorCal trial

    • Press release https://www.escardio.org/news/press/press-releases/new-data-presented-on-the-use-of-coronary-artery-calcium-for-cardiovascular-risk-assessment/
    • CorCal Outcomes: A randomized trial using the pooled cohort equation or coronary artery calcium to select statin therapy in primary prevention patients. Study design and baseline characteristics https://doi.org/10.1016/j.ahj.2026.107473

    V AMUNDSEN Trial

    • LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial InfarctionThe AMUNDSEN Randomized Clinical Trial https://jamanetwork.com/journals/jama/fullarticle/2853274

    VI TRIC-I-HF trial

    • Tricuspid Repair Cuts Death, HF Hospitalization in Severe TR https://www.medscape.com/viewarticle/tricuspid-repair-cuts-death-hf-hospitalization-severe-tr-2026a1000wvk
    • Tricuspid-Valve Intervention in Heart Failure https://www.nejm.org/doi/full/10.1056/NEJMoa2606934

    You May Also Like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Sep 04 2026 This Week in Cardiology Sep 04, 2026
    Show notes

    ESC recaps on the SINGLE-AF trial, CMR Guide trial, two ATTR studies, PVI-SHAM-AF, STAREE, and an observational study of ICD benefit over the past decades are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I SINGLE-AF Trial

    To Anticoagulate or Not in Intermediate-Risk AF: The SINGLE-AF Trial https://www.medscape.com/viewarticle/anticoagulate-or-not-intermediate-risk-af-single-af-trial-2026a1000uko

    • SINGLE-AF https://www.nejm.org/doi/10.1056/NEJMoa2607978

    II Scar as an ICD risk stratifier

    Is Scar on CMR an Indication for ICD? CMR Guide Leaves Doubts

    https://www.medscape.com/viewarticle/scar-cmr-indication-icd-cmr-guide-leaves-doubts-2026a1000ukq

    • CMTR GUIDE Trial https://jamanetwork.com/journals/jama/fullarticle/2853395
    • MADIT II Trial https://www.nejm.org/doi/full/10.1056/NEJMoa013474

    III Single vs Dual Therapy in ATTR-CM

    • HELIOS-B Trial Sub-analysis https://www.sciencedirect.com/science/article/pii/S0735109726072086
    • HELIOS-B Sub-analysis Editorial https://www.sciencedirect.com/science/article/pii/S0735109726073766#bib8
    • HELIOS-B main trial https://www.nejm.org/doi/10.1056/NEJMoa2409134
    • CARDIO-TTRansform Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2608510

    IV A Stunning Result of another Sham-controlled AF ablation trial

    Does AF Ablation Work? That's in Question After PVI-SHAM-AF https://www.medscape.com/viewarticle/does-af-ablation-work-s-question-after-sham-pvi-af-2026a1000uli

    • PVI-SHAM-AF Trial 10.1016/S0140-6736(26)01558-8 External Link
    • SHAM-PVI Trial https://jamanetwork.com/journals/jama/fullarticle/2823283
    • PFA-Sham Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079484

    V Should Older Adults Take Statins: The STAREE trial.

    STAREE Strengthens Case for Over-the-Counter Statins https://www.medscape.com/viewarticle/staree-strengthens-case-over-counter-statins-2026a1000vrw

    • STAREE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607314

    VII Declining ICD Benefit After MI

    • Mortality Reduction with ICD for Prevention of SCD Post-MI https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag706/8768943
    • CONTEMP-ICD Trial https://clinicaltrials.gov/study/NCT06543446
    • PROFID-EHRA Trial https://profid-project.eu/profid-ehra-trial/

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Aug 28 2026 This Week in Cardiology Aug 28, 2026
    Show notes

    Listener feedback on mechanical CPR devices, PFA and stroke, the Lindy effect in adopting new technology, and an ESC preview are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback on Mechanical Compression Devices for OHCA

    • Mechanical CPR Device Use and Cardiac Arrest Survival

    https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079272

    • PARAMEDIC trial https://www.thelancet.com/article/S0140-6736(14)61886-9/fulltext
    • CIRC trial https://www.resuscitationjournal.com/article/S0300-9572(14)00128-2/fulltext
    • LINC trial https://jamanetwork.com/journals/jama/fullarticle/1774037
    • Cochrane Review – Mechanical vs Manual Chest Compressions for Cardiac Arrest https://pmc.ncbi.nlm.nih.gov/articles/PMC6953326/

    II PFA and Stroke

    • Risk of Stroke and TIA With PFA vs RF Ablation https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.126.081092
    • AVANT GUARD Trial https://www.nejm.org/do/10.1056/NEJMdo008538/full/
    • EMBOL-AF Registry https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag217/8566008

    III A New ICD Lead

    • LEADR LBBAP Trial https://doi.org/10.1016/j.hrthm.2026.08.030

    IV ESC Preview

    • Mandrola's Preview of the European Society of Cardiology 2026 https://www.medscape.com/viewarticle/mandrolas-preview-european-society-cardiology-2026-2026a1000tfi

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    August 21 2026 This Week in Cardiology Aug 21, 2026
    Show notes

    Mechanical CPR devices, the dangers of AF performance measures, two scholarly articles on CLOSURE and CHAMPION, and a little ESC preview are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Mechanical Compression Devices for OHCA

    · Mechanical CPR Device Use Cardiac Arrest Survival

    https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079272

    · PARAMEDIC Trial https://www.thelancet.com/article/S0140-6736(14)61886-9/fulltext

    · CIRC Trial https://www.resuscitationjournal.com/article/S0300-9572(14)00128-2/fulltext

    · LINC trial https://jamanetwork.com/journals/jama/fullarticle/1774037

    · Cochrane Review of Mechanical vs Manual Chest Compressions for Cardiac Arrest https://pmc.ncbi.nlm.nih.gov/articles/PMC6953326/

    II ACC AF Performance Measures

    · 2026 AHA/ACC Clinical Performance for Patients With AF https://www.jacc.org/doi/10.1016/j.jacc.2026.05.032#sec-3

    III Two Critical Appraisals of the recent LAAC trials

    · Reappraising CHAMPION-AF 10.1016/j.hrthm.2026.07.048 External Link

    · CHAMPION and CLOSURE: Reconciling Contrast Results https://doi.org/10.1093/eurheartj/ehag608

    ESC Early Preview

    · CMR Guide trial https://pmc.ncbi.nlm.nih.gov/articles/PMC6931571/

    · SINGLE AF Trial 10.1016/j.hroo.2025.12.008 External Link

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Aug 14 2026 This Week in Cardiology Aug 14, 2026
    Show notes

    Listener feedback, the ZEUS trial fails, a fascinating statin trial, more on GLP-1 drugs, and radiation safety in the EP lab are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I ZEUS Fails

    Rethinking Inflammation and ASCVD: Four Lessons From the ZEUS Trial

    https://www.medscape.com/viewarticle/rethinking-inflammation-and-ascvd-four-lessons-zeus-trial-2026a1000rlm

    • ZEUS Trial https://doi.org/10.1001/jamacardio.2025.4491

    II Statins and the Elderly

    • SAGA/SITE trial 10.1016/j.lanhl.2026.100884 External Link

    III GLP-1 and CV Risk

    • SURMOUNT-1 Trial https://www.nejm.org/doi/10.1056/NEJMoa2206038
    • SURMOUNT-1 Post Hoc Analysis https://www.jacc.org/doi/10.1016/j.jacc.2026.04.044
    • Reframing GLP-1s as Cardiometabolic Health Drugs: Editorial https://www.jacc.org/doi/10.1016/j.jacc.2026.06.039

    IV Radiation Exposure to the Uterus in the EP Lab

    • Occupational Radiation Safety in EP During Pregnancy https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.126.080556
    • Survey: Working in Cath Lab During Pregnancy https://www.surveymonkey.com/share/d5c1edf7-6d99-49d4-a9fa-e9168f63ab55

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Jul 31 2026 This Week in Cardiology Jul 31, 2026
    Show notes

    Another failure of LA posterior wall isolation, first-line AF ablation, a revelation on EAST-AFNET 4 trial, an LAAC meta-analysis, and preventing AKI post-cardiac surgery are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback

    • DAPT-MVD Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2517588

    II Another Failure of Posterior Wall Isolation

    • CORNERSTONE-AF Trial https://doi.org/10.1093/eurheartj/ehag486
    • CAPLA Trial https://jamanetwork.com/journals/jama/fullarticle/2800186
    • PVIOTAL IDE Trial 10.1016/j.hrthm.2025.08.018 External Link

    III First Line AF ablation – One new study and a discovery about a second one

    • Catheter Ablation vs AAD for First-line Treatment of AF 10.1016/j.hrthm.2025.07.061 External Link
    • EAST-AFNET 4 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2019422
    • Cardiology Trials Substack https://cardiologytrials.substack.com/p/summary-and-discussion-of-east-afnet

    IV Left Atrial Appendage Closure Meta-analysis

    • Long-Term Efficacy and Safety of LAAC vs OAC -- Meta-analysis https://academic.oup.com/europace/article/28/7/euag159/8739567

    V Prevention of AKI after Cardiac Surgery: MERCURI-2

    • MERCURI-2 Study https://jamanetwork.com/journals/jama/fullarticle/2852324

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    1 2 3 43 Next

    Related Podcasts

    The Joe Rogan Experience

    1

    The Joe Rogan Experience Comedy
    More Perfect

    2

    More Perfect Government
    Casefile True Crime

    3

    Casefile True Crime Games & Hobbies
    Reply All

    4

    Reply All Games & Hobbies
    You Must Remember This

    5

    You Must Remember This Games & Hobbies
    Real Time with Bill Maher

    6

    Real Time with Bill Maher Games & Hobbies
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights